Observational studyMedicine2017

Treatment inferred from mutations identified using massive parallel sequencing leads to clinical benefit in some heavily pretreated cancer patients.

Aviad Zick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.